In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

RIFM dermal absorption symposium

This article was originally published in The Rose Sheet

Executive Summary

The Research Institute for Fragrance Materials will hold a symposium "to provide information on [its] current understanding of the mechanics of skin absorption and present the experimental methods available to assess percutaneous penetration." Symposium will take place Nov. 13 at the American College of Toxicology's annual meeting in Charlotte, North Carolina. The absorption of compounds through the skin - whether incidental or by design - may be associated with toxicological hazards, RIFM notes, stressing that exposure quantification and risk assessment are needed to protect human health. Attendees of the symposium also will gain insight into the latest developments in mathematical/physiological dermal absorption modeling and take away a comparative analysis of available assessment methods using fragrance ingredients as an example. Those interested can register at 1www.actox.org...
UsernamePublicRestriction

Register

RS015021

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel